| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 15 |
| 1 | METHOTREXATE SODIUM | 14 |
| 2 | METHOTREXATE | 13 |
| 3 | RIVAROXABAN | 13 |
| 4 | IRBESARTAN | 12 |
| 5 | OMEPRAZOLE | 12 |
| 6 | OMEPRAZOLE MAGNESIUM | 12 |
| 7 | SITAGLIPTIN | 12 |
| 8 | HYDROCHLOROTHIAZIDE | 11 |
| 9 | METFORMIN | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 1 | CLEVIDIPINE | 1 | 0.0027 |
| 2 | DUVELISIB | 2 | 0.0023 |
| 3 | TRIPTORELIN | 4 | 0.0012 |
| 4 | NERANDOMILAST | 2 | 0.0012 |
| 5 | WHITE PETROLATUM | 1 | 0.0007 |
| 6 | GILTERITINIB | 2 | 0.0005 |
| 7 | DECITABINE | 2 | 0.0005 |
| 8 | NITRIC OXIDE | 2 | 0.0004 |
| 9 | PONATINIB HYDROCHLORIDE | 2 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 16 |
| 1 | Corticosteroid [EPC] | 15 |
| 2 | Angiotensin 2 Receptor Blocker [EPC] | 14 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 14 |
| 4 | Proton Pump Inhibitor [EPC] | 14 |
| 5 | Factor Xa Inhibitor [EPC] | 13 |
| 6 | Microtubule Inhibitor [EPC] | 13 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 12 |
| 8 | Thiazide Diuretic [EPC] | 11 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 12 | 0.0004 |
| 1 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 2 | Anti-anginal [EPC] | 2 | 0.0002 |
| 3 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 4 | HER2/neu Receptor Antagonist [EPC] | 9 | 0.0001 |
| 5 | Microtubule Inhibitor [EPC] | 13 | 0.0001 |
| 6 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 7 | Anticholinergic [EPC] | 1 | 0.0001 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 2 | 0.0001 |
| 9 | Thiazide Diuretic [EPC] | 11 | 0.0001 |